New York Regional Center for Diabetes Translation Research

纽约糖尿病翻译研究区域中心

• 批准号: 10290452
• 负责人: JEFFREY S GONZALEZ
• 金额: $ 22.28万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-20 至 2026-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10290452
• 关键词: Advisory Committees; Awareness; Behavioral Sciences; Biometry; Communities; Consultations; Country; Development; Diabetes Mellitus; Disadvantaged; Doctor of Philosophy; Ensure; Ethics; Evaluation; Evolution; Faculty; Funding; Funding Opportunities; Goals; Grant; Growth; Health; Health system; Infrastructure; Institutes; Institution; Investments; Latino; Leadership; Life Cycle Stages; Maintenance; Medicine; Mentors; Methodology; Mission; National Institute of Diabetes and Digestive and Kidney Diseases; New York; Obesity; Outcome; Performance; Procedures; Process; Productivity; Program Evaluation; Quality Control; Reporting; Research; Research Design; Research Personnel; Research Proposals; Resources; Services; System; Technology; Time; Translational Research; Translations; United States National Institutes of Health; Vision; Work; base; college; cost efficient; diabetes risk; expectation; flexibility; health equity; improved; innovation; interest; member; next generation; population health; programs; racial and ethnic; racial minority; success; translational scientist; web site

Administrative Core The Administrative (ADM) Core of the New York Regional Center for Diabetes Translation Research (NY- CDTR) provides the fundamental infrastructure necessary to strengthen such research at the Albert Einstein College of Medicine with Montefiore Health Systems, and other diverse partnering institutions of our Core faculty and members to stimulate the next generation of diabetes translation research through the following aims: 1) To provide dynamic and responsive leadership. The ADM will afford consistent scientific leadership to articulate and implement a clear vision for the translational research direction of the Center. The Program Director, Jeffrey Gonzalez, PhD, will provide strong and responsive leadership to accelerate translational research on diabetes and obesity that contributes to health equity in diabetes outcomes for ethnic/racial minorities, the poor and disadvantaged, and other marginalized groups. 2) To provide robust infrastructure for the maintenance of four cutting edge Translational Research Cores. We have developed and refined four Translational Research Cores furnishing the infrastructural bedrock of the NY-CDTR: Behavioral Science and Technology Core; Life Course Methodology Core; Population Health and Health Systems Core; and the Latino Network for Diabetes Translation Research, a National Resource Core. 3) To administer vibrant Center Programs, including an Enrichment Program and a Pilot and Feasibility (P&F) Grant Program. The ADM will leverage the many resources of our collaborating academic institutions, funded Centers and CTSAs, so that the Enrichment Program activities are accessible for members as well as potential new members; there is also a heightened awareness of the wealth of educational programs for diabetes translational investigators focused on health equity research. The ADM will also provide infrastructure and support for the robust, mentored P&F Program to fund promising research proposals from early stage investigator members. Maintenance of a useful and up-to-date NY-CDTR website will make these resources accessible to our members and non-members across the country. We will also stimulate and promote use of diversity supplements throughout our national network. 4) To objectively evaluate progress, facilitate efficiency, and ensure ethical conduct of research, and quality control, with guidance from multi-stakeholder and community-based advisors. The ADM institutes a system of reportage and evaluation to ensure that services meet expectations; initiatives continue to be effective; progress is reported in a timely and comprehensive manner; and established objectives continue to be met. The ADM will work with an Internal Advisory Committee and External Scientific Advisory Committee to ensure the cost-efficient and high impact performance of all Center activities to guide the evolution of the NY- CDTR toward the next generation of diabetes translation research that is responsive to community needs and priorities, funding opportunities, and developments in technology.

行政核心 糖尿病翻译研究纽约区域中心（纽约- CDTR）提供了必要的基本基础设施，以加强在阿尔伯特爱因斯坦研究所的研究 医学院与蒙蒂菲奥里卫生系统，以及我们的核心其他不同的合作机构 教师和成员通过以下方式促进下一代糖尿病翻译研究 目标：1）提供有活力和反应迅速的领导。ADM将提供一致的科学领导， 阐明并实施该中心的翻译研究方向的清晰愿景。程序 主任，杰弗里冈萨雷斯博士，将提供强有力的和反应迅速的领导，以加快翻译 关于糖尿病和肥胖症的研究，有助于种族/种族糖尿病结局的健康公平性 少数群体、穷人和弱势群体以及其他边缘化群体。2)提供强大的基础设施， 四个前沿转化研究核心的维护。我们已经开发和完善了四个 转化研究核心提供了NY-CDTR的基础设施基石：行为科学和 技术核心;生命过程方法核心;人口健康和健康系统核心;拉丁美洲人 糖尿病翻译研究网络，国家资源核心。3)管理充满活力的中心 计划，包括丰富计划和试点和可行性（P&F）赠款计划。ADM将 利用我们合作的学术机构、资助中心和CTSA的许多资源， 会员和潜在的新会员都可以参加丰富计划活动;此外， 对糖尿病转化研究者的丰富教育计划的高度认识， 关于健康公平的研究。ADM还将为强大的、有指导的P&F提供基础设施和支持 计划资助有前途的研究建议，从早期阶段的研究成员。维护一个有用的 最新的NY-CDTR网站将使我们的成员和非成员可以访问这些资源 全国各地我们还将鼓励和促进在全国范围内使用多样性补充剂。 网络4)客观评估进展，提高效率，确保研究的道德行为， 在多方利益攸关方和社区顾问的指导下进行质量控制。ADM研究所a 报告和评价制度，以确保服务达到预期;各项倡议继续 有效;及时和全面地报告进展情况;既定目标继续 得到满足ADM将与内部咨询委员会和外部科学咨询委员会合作， 确保所有中心活动的成本效益和高影响力，以指导纽约的发展， CDTR致力于下一代糖尿病翻译研究，以满足社区需求， 优先事项、筹资机会和技术发展。